Physician profile

Eva Laukhuf

Bradenton, FL

NPI 1932201282

$5,453.86

in general payments reported to CMS, 2019-2025

33 companies · $649 in 2025

The $649 reported for 2025 was more than what 83% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,220.89

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $792.24 2019-2025 Rybelsus, Ozempic
Pfizer INC. $657.15 2019-2025
Abbvie INC. $612.75 2021-2025
Lilly USA, LLC $473.95 2020-2025 Mounjaro, Zepbound, Kisunla
Exact Sciences Corporation $362.73 2023-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Boehringer Ingelheim Pharmaceuticals, INC. $254.58 2019-2025 Jardiance, Tradjenta
Glaxosmithkline, LLC. $248.01 2019-2025 Trelegy Ellipta, Arexvy, Shingrix
Amgen INC. $210.51 2019-2025 Otezla, Repatha, Repatha
Astellas Pharma US INC $202.77 2019-2024 Veozah
Novartis Pharmaceuticals Corporation $175.54 2019-2025
Biohaven Pharmaceutical Holding Company LTD. $164.73 2022
Janssen Pharmaceuticals, INC $158.73 2019-2022
Ge Healthcare $135.69 2025
Biogen, INC. $120.60 2021
Eisai INC. $112.29 2020-2024
Show all 33 companies
CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $97.94 2019-2024 Airsupra
Merck Sharp & Dohme LLC $84.61 2020-2023 Belsomra
Allergan, INC. $73.34 2019-2020
Bayer Healthcare Pharmaceuticals INC. $72.83 2023-2025
Biohaven Pharmaceuticals, INC. $69.36 2021
Abbott Laboratories $60.06 2022-2024 Freestyle Libre 3
Grt US Holding, INC. $53.75 2022
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $51.33 2025 Xifaxan
Hologic Sales and Service, LLC $43.79 2021-2025 Thinprep 2000 Processor, Aptima
Esperion Therapeutics, INC. $35.34 2021
Ultragenyx Pharmaceutical INC. $22.63 2023 Crysvita
Idorsia Pharmaceuticals US INC $18.70 2023 Quviviq
Boston Scientific Corporation $17.85 2023 Watchman Access System
Teva Pharmaceuticals USA, INC. $14.96 2020
Ardelyx, INC. $14.41 2023 Ibsrela
Inari Medical, INC. $14.00 2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Kowa Pharmaceuticals America, INC. $13.91 2025 Zoryve
Therapeuticsmd, INC. $12.78 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eva Laukhuf

$5,453.86

in general payments reported 2019-2025

Years
2019-2025
Top company
Novo Nordisk INC
Context
The $649 reported for 2025 was more than what 83% of providers received nationally.

https://glasscript.com/doctor/41893/eva-laukhuf

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.